Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients

Clinical Chemistry

Volumn 49, Issue 3, 2003, Pages 450-454

  Rossi, Enrico ^a,d   Adams, Leon ^b   Prins, Alexander ^a   Bulsara, Max ^c   De Boer, Bastiaan ^a   Garas, George ^b   MacQuillan, Gerry ^c   Speers, David ^a   Jeffrey, Gary ^b,c  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Clinical Biochemistry   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN;

ADULT; ARTICLE; BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; STAGING; VALIDATION PROCESS;

ADULT; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MALE; PREVALENCE; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS;

EID: 0037371363     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.3.450     Document Type: Article

References (15)

1. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology 2000;32:477-81.
2. Poynard T, Ratziu V, Benmanov Y, Di Martino V, Bedossa P, Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance [Review]. Semin Liver Dis 2000;120:47-55.
3. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-75.
4. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93.
5. StataCorp. Stata statistical software: release 7.0. Collage Station, TX: Stata Corporation, 2001.
6. Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 2002;9:128-33.
7. Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T. Groupe d'Etude Multidisciplinaire sur les Pathologies Liees au Virus C. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol 2002;97:2419-25.
8. Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. α-2-Macroglobulin and hepatic fibrosis. Diagnostic interest. Dig Dis Sci 1994;39:2426-32.
9. Poynard T, Aubert A, Bedossa P, Abella A, Naveau S, Paraf F, et al. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991;100:1397-402.
10. Bacq Y, Schillio Y, Brechot JF, De Muret A, Dubois F, Metman EH. Decrease of haptoglobin serum level in patients with chronic viral hepatitis C. Gastroenterol Clin Biol 1993;17:364-9.
11. Fortunato G, Castaldo G, Oriani G, Cerini R, Intrieri M, Molinaro E, et al. Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clin Chem 2001;47:1696-700.
12. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-92.
13. Oh S, Afdhal NH. Hepatic fibrosis: are any of the serum markers useful? Curt Gastroenterol Rep 2001;3:12-8.
14. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat 1998;5:187-92.
15. Lichtinghagen R, Huegel O, Seifert T, Haberkorn CI, Michels D, Flemming P, et al. Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin Chem 2000;46:183-92.